ANGI Form 4: 16.4K RSU Award to Director Thomas Pickett

Rhea-AI Filing Summary

Angi Inc. (ANGI) – Form 4 Insider Transaction Summary

Director Thomas C. Pickett reported the grant of 16,436 restricted stock units (RSUs) on 17 June 2025. Each RSU represents the right to receive one share of Angi’s Class A common stock at no cost when vested. The award vests in three equal annual instalments on each anniversary of the grant date, contingent on Mr. Pickett’s continued service. Any vested units will be settled in a lump-sum distribution after termination of service pursuant to the director’s deferral election. Following this grant, Mr. Pickett beneficially owns 16,436 derivative securities, held directly. No open-market purchase or sale occurred, and no cash consideration was exchanged.

No other equity transactions or changes in ownership were disclosed in the filing.

Insights

Financial Analyst

TL;DR: Routine director RSU grant; minimal immediate share impact; neutral for valuation.

The filing shows a standard equity compensation award—16,436 RSUs—to Director Thomas Pickett. Because RSUs are non-cash and vest over three years, dilution is marginal (<0.03 % of basic shares, assuming ~65 million shares outstanding). There is no buying or selling signal; therefore, it neither materially alters float nor reveals sentiment. Investors typically view such grants as alignment tools rather than catalysts. Consequently, I classify the disclosure as neutral and not price-moving.

Corporate Governance Expert

TL;DR: Grant supports board-shareholder alignment; governance-positive but immaterial financially.

Regular equity grants to directors are good governance practice, encouraging long-term focus. The three-year vesting schedule ties Mr. Pickett’s interests to sustained performance. However, the volume is modest and settlement occurs post-service, limiting near-term alignment incentives. There are no red flags—such as accelerated vesting or unusual pricing—so the disclosure remains routine.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pickett Thomas Corning Jr

(Last) (First) (Middle)

C/O ANGI INC.

3601 WALNUT STREET, SUITE 700

(Street)

DENVER CO 80205

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Angi Inc. [ ANGI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/17/2025		A		16,436		(2)	(2)	Class A Common Stock, par value $0.001	16,436	$0	16,436	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock.

2. Represents RSUs that vest in equal installments over three years on the anniversary of the grant date (June 17, 2025), subject to continued service. Pursuant to the reporting person's deferral election, any vested RSUs will be settled in a lump sum following termination of service.

Remarks:

	Shannon M. Shaw as Attorney-in-Fact for Thomas C. Pickett	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Angi (ANGI) shares were granted to Director Thomas C. Pickett?

The filing reports 16,436 restricted stock units, each convertible to one Class A share upon vesting.

What is the vesting schedule for the RSUs granted on June 17, 2025?

The RSUs vest in three equal annual instalments on each anniversary of the grant date, subject to continued service.

Did the insider buy or sell Angi shares on the open market?

No. No open-market transactions were reported; the Form 4 only discloses an equity award.

What is the exercise price of the derivative security?

The RSUs have no exercise price ($0); they convert one-for-one into common shares when vested.

Does this Form 4 filing materially affect Angi's share count?

The impact is immaterial. Dilution from 16,436 shares is negligible relative to Angi’s total outstanding shares.